Completed PHASE4 INTERVENTIONAL 2-arm NCT02657031

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.

Sponsor: University Medical Center of Southern Nevada

Conditions Headache

Interventions Diphenhydramine Ketamine Normal Saline Ondansetron Prochlorperazine

Updated 8 times since 2017 Last updated: Dec 7, 2017 Started: Mar 17, 2016 Primary completion: Mar 21, 2017 Completion: Mar 21, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Headache and is currently completed. University Medical Center of Southern Nevada leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Dec 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Apr 2017 — Dec 2017 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Feb 2017 — Apr 2017 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Medical Center of Southern Nevada

Data source: University Medical Center of Southern Nevada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Las Vegas, United States